These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12907443)

  • 21. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia.
    Ley TJ; DeSimone J; Noguchi CT; Turner PH; Schechter AN; Heller P; Nienhuis AW
    Blood; 1983 Aug; 62(2):370-80. PubMed ID: 6191799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.
    Kutlar A; Ataga K; Reid M; Vichinsky EP; Neumayr L; Blair-Britt L; Labotka R; Glass J; Keefer JR; Wargin WA; Berenson R; Perrine SP
    Am J Hematol; 2012 Nov; 87(11):1017-21. PubMed ID: 22887019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decitabine increases fetal hemoglobin in Papio anubis by increasing γ-globin gene transcription.
    Akpan I; Banzon V; Ibanez V; Vaitkus K; DeSimone J; Lavelle D
    Exp Hematol; 2010 Nov; 38(11):989-993.e1. PubMed ID: 20713129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
    Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.
    Mabaera R; Greene MR; Richardson CA; Conine SJ; Kozul CD; Lowrey CH
    Blood; 2008 Jan; 111(1):411-20. PubMed ID: 17916742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers.
    Breda L; Motta I; Lourenco S; Gemmo C; Deng W; Rupon JW; Abdulmalik OY; Manwani D; Blobel GA; Rivella S
    Blood; 2016 Aug; 128(8):1139-43. PubMed ID: 27405777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
    Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
    Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of increased fetal hemoglobin production on the frequency of vaso-occlusive crisis in sickle cell disease.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1987; 240():277-85. PubMed ID: 2441416
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium.
    Haynes J; Obiako B; Hester RB; Baliga BS; Stevens T
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H379-85. PubMed ID: 17993595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
    Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
    Charache S; Dover G; Smith K; Talbot CC; Moyer M; Boyer S
    Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4842-6. PubMed ID: 6192443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobinopathies.
    Atweh GF; DeSimone J; Saunthararajah Y; Fathallah H; Weinberg RS; Nagel RL; Fabry ME; Adams RJ
    Hematology Am Soc Hematol Educ Program; 2003; ():14-39. PubMed ID: 14633775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
    Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
    Momparler RL; Côté S; Eliopoulos N
    Leukemia; 1997 Feb; 11(2):175-80. PubMed ID: 9009076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal hemoglobin in sickle cell anemia: a glass half full?
    Steinberg MH; Chui DH; Dover GJ; Sebastiani P; Alsultan A
    Blood; 2014 Jan; 123(4):481-5. PubMed ID: 24222332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.